CreativeOne Wealth’s Zevra Therapeutics ZVRA Stock Holding History

CreativeOne Wealth’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,604	Closed	-$10K	–	241
2019 Q4	$10K	Hold	1,604	–	–	﹤0.01%	220
2019 Q3	$18K	Hold	1,604	–	–	﹤0.01%	178
2019 Q2	$45K	Sell	1,604 -750	-32%	-$18.9K	0.01%	173
2019 Q1	$63K	Hold	2,354	–	–	0.02%	129
2018 Q4	$67K	Buy	+2,354	New	+$95.3K	0.02%	104
2018 Q3	–	Sell	-2,461	Closed	-$256K	–	71
2018 Q2	$256K	Sell	2,461 -1,331	-35%	-$130K	0.11%	45
2018 Q1	$479K	Buy	+3,792	New	+$367K	0.24%	31

Other funds holding ZVRA

DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

RFN

RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CreativeOne Wealth's ZVRA Position: Q1 2020 in Review

CreativeOne Wealth sold out of Zevra Therapeutics (ZVRA) in Q1 2020, closing a stake of 1,604 shares — an estimated $10K sold.

CreativeOne Wealth first reported a position in ZVRA in Q1 2018 and held it in 7 quarters. The position peaked at $479K in Q1 2018. 29 funds tracked by Wall St. Rank hold ZVRA as of Q1 2020.

CreativeOne Wealth reported no remaining Zevra Therapeutics position as of Q1 2020 after selling out during the quarter.
CreativeOne Wealth sold 1,604 Zevra Therapeutics shares in Q1 2020, an estimated $10K.
CreativeOne Wealth first reported a position in Zevra Therapeutics in Q1 2018 and held it in 7 quarters.
CreativeOne Wealth's Zevra Therapeutics position peaked at $479K in Q1 2018.
29 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2020.

Based on CreativeOne Wealth's 13F filing for Q1 2020, filed 14 May 2020.